The global market for Drugs Based on CAR T-cell was valued at US$ 5187 million in the year 2024 and is projected to reach a revised size of US$ 31630 million by 2031, growing at a CAGR of 29.9% during the forecast period.

Drugs Based on CAR T-cell Market

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer

The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patient"s own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments.

This report aims to provide a comprehensive presentation of the global market for Drugs Based on CAR T-cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs Based on CAR T-cell.

The Drugs Based on CAR T-cell market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs Based on CAR T-cell market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs Based on CAR T-cell companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drugs Based on CAR T-cell Market Report

Report Metric	Details
Report Name	Drugs Based on CAR T-cell Market
Accounted market size in year	US$ 5187 million
Forecasted market size in 2031	US$ 31630 million
CAGR	29.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	CD19-targeted BCMA-targeted
Segment by Application	Lymphoma Multiple Myeloma
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs Based on CAR T-cell company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drugs Based on CAR T-cell Market growing?

Ans: The Drugs Based on CAR T-cell Market witnessing a CAGR of 29.9% during the forecast period 2025-2031.

What is the Drugs Based on CAR T-cell Market size in 2031?

Ans: The Drugs Based on CAR T-cell Market size in 2031 will be US$ 31630 million.

Who are the main players in the Drugs Based on CAR T-cell Market report?

Ans: The main players in the Drugs Based on CAR T-cell Market are Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite

What are the Application segmentation covered in the Drugs Based on CAR T-cell Market report?

Ans: The Applications covered in the Drugs Based on CAR T-cell Market report are Lymphoma, Multiple Myeloma

What are the Type segmentation covered in the Drugs Based on CAR T-cell Market report?

Ans: The Types covered in the Drugs Based on CAR T-cell Market report are CD19-targeted, BCMA-targeted

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs Based on CAR T-cell Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CD19-targeted

1.2.3 BCMA-targeted

1.3 Market by Application

1.3.1 Global Drugs Based on CAR T-cell Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Lymphoma

1.3.3 Multiple Myeloma

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs Based on CAR T-cell Market Perspective (2020-2031)

2.2 Global Drugs Based on CAR T-cell Growth Trends by Region

2.2.1 Global Drugs Based on CAR T-cell Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drugs Based on CAR T-cell Historic Market Size by Region (2020-2025)

2.2.3 Drugs Based on CAR T-cell Forecasted Market Size by Region (2026-2031)

2.3 Drugs Based on CAR T-cell Market Dynamics

2.3.1 Drugs Based on CAR T-cell Industry Trends

2.3.2 Drugs Based on CAR T-cell Market Drivers

2.3.3 Drugs Based on CAR T-cell Market Challenges

2.3.4 Drugs Based on CAR T-cell Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs Based on CAR T-cell Players by Revenue

3.1.1 Global Top Drugs Based on CAR T-cell Players by Revenue (2020-2025)

3.1.2 Global Drugs Based on CAR T-cell Revenue Market Share by Players (2020-2025)

3.2 Global Drugs Based on CAR T-cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drugs Based on CAR T-cell Revenue

3.4 Global Drugs Based on CAR T-cell Market Concentration Ratio

3.4.1 Global Drugs Based on CAR T-cell Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs Based on CAR T-cell Revenue in 2024

3.5 Global Key Players of Drugs Based on CAR T-cell Head office and Area Served

3.6 Global Key Players of Drugs Based on CAR T-cell, Product and Application

3.7 Global Key Players of Drugs Based on CAR T-cell, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs Based on CAR T-cell Breakdown Data by Type

4.1 Global Drugs Based on CAR T-cell Historic Market Size by Type (2020-2025)

4.2 Global Drugs Based on CAR T-cell Forecasted Market Size by Type (2026-2031)

5 Drugs Based on CAR T-cell Breakdown Data by Application

5.1 Global Drugs Based on CAR T-cell Historic Market Size by Application (2020-2025)

5.2 Global Drugs Based on CAR T-cell Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drugs Based on CAR T-cell Market Size (2020-2031)

6.2 North America Drugs Based on CAR T-cell Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drugs Based on CAR T-cell Market Size by Country (2020-2025)

6.4 North America Drugs Based on CAR T-cell Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs Based on CAR T-cell Market Size (2020-2031)

7.2 Europe Drugs Based on CAR T-cell Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drugs Based on CAR T-cell Market Size by Country (2020-2025)

7.4 Europe Drugs Based on CAR T-cell Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drugs Based on CAR T-cell Market Size (2020-2031)

8.2 Asia-Pacific Drugs Based on CAR T-cell Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drugs Based on CAR T-cell Market Size by Region (2020-2025)

8.4 Asia-Pacific Drugs Based on CAR T-cell Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drugs Based on CAR T-cell Market Size (2020-2031)

9.2 Latin America Drugs Based on CAR T-cell Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drugs Based on CAR T-cell Market Size by Country (2020-2025)

9.4 Latin America Drugs Based on CAR T-cell Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs Based on CAR T-cell Market Size (2020-2031)

10.2 Middle East & Africa Drugs Based on CAR T-cell Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drugs Based on CAR T-cell Market Size by Country (2020-2025)

10.4 Middle East & Africa Drugs Based on CAR T-cell Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Drugs Based on CAR T-cell Introduction

11.1.4 Novartis Revenue in Drugs Based on CAR T-cell Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Details

11.2.2 Gilead Sciences Business Overview

11.2.3 Gilead Sciences Drugs Based on CAR T-cell Introduction

11.2.4 Gilead Sciences Revenue in Drugs Based on CAR T-cell Business (2020-2025)

11.2.5 Gilead Sciences Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Introduction

11.3.4 Bristol-Myers Squibb Revenue in Drugs Based on CAR T-cell Business (2020-2025)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 J & J

11.4.1 J & J Company Details

11.4.2 J & J Business Overview

11.4.3 J & J Drugs Based on CAR T-cell Introduction

11.4.4 J & J Revenue in Drugs Based on CAR T-cell Business (2020-2025)

11.4.5 J & J Recent Development

11.5 JW Therapeutics

11.5.1 JW Therapeutics Company Details

11.5.2 JW Therapeutics Business Overview

11.5.3 JW Therapeutics Drugs Based on CAR T-cell Introduction

11.5.4 JW Therapeutics Revenue in Drugs Based on CAR T-cell Business (2020-2025)

11.5.5 JW Therapeutics Recent Development

11.6 FOSUNKite

11.6.1 FOSUNKite Company Details

11.6.2 FOSUNKite Business Overview

11.6.3 FOSUNKite Drugs Based on CAR T-cell Introduction

11.6.4 FOSUNKite Revenue in Drugs Based on CAR T-cell Business (2020-2025)

11.6.5 FOSUNKite Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Drugs Based on CAR T-cell Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CD19-targeted

Table 3. Key Players of BCMA-targeted

Table 4. Global Drugs Based on CAR T-cell Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Drugs Based on CAR T-cell Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Drugs Based on CAR T-cell Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Drugs Based on CAR T-cell Market Share by Region (2020-2025)

Table 8. Global Drugs Based on CAR T-cell Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Drugs Based on CAR T-cell Market Share by Region (2026-2031)

Table 10. Drugs Based on CAR T-cell Market Trends

Table 11. Drugs Based on CAR T-cell Market Drivers

Table 12. Drugs Based on CAR T-cell Market Challenges

Table 13. Drugs Based on CAR T-cell Market Restraints

Table 14. Global Drugs Based on CAR T-cell Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Drugs Based on CAR T-cell Market Share by Players (2020-2025)

Table 16. Global Top Drugs Based on CAR T-cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on CAR T-cell as of 2024)

Table 17. Ranking of Global Top Drugs Based on CAR T-cell Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Drugs Based on CAR T-cell Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Drugs Based on CAR T-cell, Headquarters and Area Served

Table 20. Global Key Players of Drugs Based on CAR T-cell, Product and Application

Table 21. Global Key Players of Drugs Based on CAR T-cell, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Drugs Based on CAR T-cell Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Drugs Based on CAR T-cell Revenue Market Share by Type (2020-2025)

Table 25. Global Drugs Based on CAR T-cell Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Drugs Based on CAR T-cell Revenue Market Share by Type (2026-2031)

Table 27. Global Drugs Based on CAR T-cell Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Drugs Based on CAR T-cell Revenue Market Share by Application (2020-2025)

Table 29. Global Drugs Based on CAR T-cell Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Drugs Based on CAR T-cell Revenue Market Share by Application (2026-2031)

Table 31. North America Drugs Based on CAR T-cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Drugs Based on CAR T-cell Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Drugs Based on CAR T-cell Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Drugs Based on CAR T-cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Drugs Based on CAR T-cell Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Drugs Based on CAR T-cell Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Drugs Based on CAR T-cell Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Drugs Based on CAR T-cell Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Drugs Based on CAR T-cell Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Drugs Based on CAR T-cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Drugs Based on CAR T-cell Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Drugs Based on CAR T-cell Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Drugs Based on CAR T-cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Drugs Based on CAR T-cell Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Drugs Based on CAR T-cell Market Size by Country (2026-2031) & (US$ Million)

Table 46. Novartis Company Details

Table 47. Novartis Business Overview

Table 48. Novartis Drugs Based on CAR T-cell Product

Table 49. Novartis Revenue in Drugs Based on CAR T-cell Business (2020-2025) & (US$ Million)

Table 50. Novartis Recent Development

Table 51. Gilead Sciences Company Details

Table 52. Gilead Sciences Business Overview

Table 53. Gilead Sciences Drugs Based on CAR T-cell Product

Table 54. Gilead Sciences Revenue in Drugs Based on CAR T-cell Business (2020-2025) & (US$ Million)

Table 55. Gilead Sciences Recent Development

Table 56. Bristol-Myers Squibb Company Details

Table 57. Bristol-Myers Squibb Business Overview

Table 58. Bristol-Myers Squibb Drugs Based on CAR T-cell Product

Table 59. Bristol-Myers Squibb Revenue in Drugs Based on CAR T-cell Business (2020-2025) & (US$ Million)

Table 60. Bristol-Myers Squibb Recent Development

Table 61. J & J Company Details

Table 62. J & J Business Overview

Table 63. J & J Drugs Based on CAR T-cell Product

Table 64. J & J Revenue in Drugs Based on CAR T-cell Business (2020-2025) & (US$ Million)

Table 65. J & J Recent Development

Table 66. JW Therapeutics Company Details

Table 67. JW Therapeutics Business Overview

Table 68. JW Therapeutics Drugs Based on CAR T-cell Product

Table 69. JW Therapeutics Revenue in Drugs Based on CAR T-cell Business (2020-2025) & (US$ Million)

Table 70. JW Therapeutics Recent Development

Table 71. FOSUNKite Company Details

Table 72. FOSUNKite Business Overview

Table 73. FOSUNKite Drugs Based on CAR T-cell Product

Table 74. FOSUNKite Revenue in Drugs Based on CAR T-cell Business (2020-2025) & (US$ Million)

Table 75. FOSUNKite Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Drugs Based on CAR T-cell Picture

Figure 2. Global Drugs Based on CAR T-cell Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drugs Based on CAR T-cell Market Share by Type: 2024 VS 2031

Figure 4. CD19-targeted Features

Figure 5. BCMA-targeted Features

Figure 6. Global Drugs Based on CAR T-cell Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Drugs Based on CAR T-cell Market Share by Application: 2024 VS 2031

Figure 8. Lymphoma Case Studies

Figure 9. Multiple Myeloma Case Studies

Figure 10. Drugs Based on CAR T-cell Report Years Considered

Figure 11. Global Drugs Based on CAR T-cell Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Drugs Based on CAR T-cell Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Drugs Based on CAR T-cell Market Share by Region: 2024 VS 2031

Figure 14. Global Drugs Based on CAR T-cell Market Share by Players in 2024

Figure 15. Global Top Drugs Based on CAR T-cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on CAR T-cell as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Drugs Based on CAR T-cell Revenue in 2024

Figure 17. North America Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Drugs Based on CAR T-cell Market Share by Country (2020-2031)

Figure 19. United States Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Drugs Based on CAR T-cell Market Share by Country (2020-2031)

Figure 23. Germany Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Drugs Based on CAR T-cell Market Share by Region (2020-2031)

Figure 31. China Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Drugs Based on CAR T-cell Market Share by Country (2020-2031)

Figure 39. Mexico Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Drugs Based on CAR T-cell Market Share by Country (2020-2031)

Figure 43. Turkey Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Drugs Based on CAR T-cell Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Novartis Revenue Growth Rate in Drugs Based on CAR T-cell Business (2020-2025)

Figure 47. Gilead Sciences Revenue Growth Rate in Drugs Based on CAR T-cell Business (2020-2025)

Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Drugs Based on CAR T-cell Business (2020-2025)

Figure 49. J & J Revenue Growth Rate in Drugs Based on CAR T-cell Business (2020-2025)

Figure 50. JW Therapeutics Revenue Growth Rate in Drugs Based on CAR T-cell Business (2020-2025)

Figure 51. FOSUNKite Revenue Growth Rate in Drugs Based on CAR T-cell Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions